Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020.
Howard Kaufman
No relevant relationships to disclose
Jose Lutzky
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Joseph Clark
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Kim Allyson Margolin
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
David H. Lawson
Consultant or Advisory Role - Bristol-Myers Squibb; Genzyme; Roche
Honoraria - Bristol-Myers Squibb; Genzyme
Asim Amin
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Frances A. Collichio
Consultant or Advisory Role - Amgen
Research Funding - Amgen; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Morphotek; Roche
Andrew Pecora
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Walter John Urba
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Kelly L. Bennett
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb